SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.
Tayek
J
J
D018528:ATP-Binding Cassette Transporters / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D005905:Glyburide / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced* / Q000378:metabolism / Q000401:mortality; D024661:Potassium Channels, Inwardly Rectifying / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*; D013453:Sulfonylurea Compounds / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D064233:Sulfonylurea Receptors
D018528:ATP-Binding Cassette Transporters; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug; D013453:Sulfonylurea Compounds; D064233:Sulfonylurea Receptors; C057619:glimepiride; D005905:Glyburide